Lars Møller

3.6k total citations
56 papers, 1.6k citations indexed

About

Lars Møller is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Lars Møller has authored 56 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 13 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Lars Møller's work include SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (7 papers) and Viral gastroenteritis research and epidemiology (7 papers). Lars Møller is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (7 papers) and Viral gastroenteritis research and epidemiology (7 papers). Lars Møller collaborates with scholars based in Denmark, Germany and Faroe Islands. Lars Møller's co-authors include Gauden Galea, Peter Anderson, Hanne Kristine Hegaard, Hanne Wacher Kjærgaard, Bent Ottesen, Michael Farrell, Heino Stöver, Soraya Mayet, Paula Alves and Dagmar Hedrich and has published in prestigious journals such as The Lancet, Nature Communications and PLoS ONE.

In The Last Decade

Lars Møller

54 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Møller Denmark 23 558 355 276 248 240 56 1.6k
Phoebe Williams Australia 23 641 1.1× 490 1.4× 326 1.2× 88 0.4× 234 1.0× 98 1.9k
Jenell S. Coleman United States 22 568 1.0× 374 1.1× 325 1.2× 132 0.5× 290 1.2× 79 1.5k
Manas K. Akmatov Germany 22 577 1.0× 332 0.9× 119 0.4× 143 0.6× 217 0.9× 91 1.7k
Joann Schulte United States 20 705 1.3× 551 1.6× 190 0.7× 110 0.4× 208 0.9× 57 1.9k
Domenico Martinelli Italy 29 1.2k 2.2× 648 1.8× 241 0.9× 263 1.1× 117 0.5× 168 2.9k
Yasmin Khaliq Canada 13 306 0.5× 315 0.9× 323 1.2× 98 0.4× 291 1.2× 15 1.6k
Massimo Pettoello‐Mantovani Italy 31 665 1.2× 333 0.9× 284 1.0× 497 2.0× 376 1.6× 137 3.2k
Gayatri Jayaraman Canada 21 552 1.0× 320 0.9× 362 1.3× 103 0.4× 361 1.5× 60 1.5k
Stan Houston Canada 24 543 1.0× 620 1.7× 179 0.6× 103 0.4× 226 0.9× 96 1.5k
Jozefien Buyze Belgium 22 723 1.3× 693 2.0× 182 0.7× 173 0.7× 320 1.3× 79 1.6k

Countries citing papers authored by Lars Møller

Since Specialization
Citations

This map shows the geographic impact of Lars Møller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Møller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Møller more than expected).

Fields of papers citing papers by Lars Møller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Møller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Møller. The network helps show where Lars Møller may publish in the future.

Co-authorship network of co-authors of Lars Møller

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Møller. A scholar is included among the top collaborators of Lars Møller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Møller. Lars Møller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wolf, Silver A., Emanuel Wyler, Lars Møller, et al.. (2023). Rat cytomegalovirus efficiently replicates in dendritic cells and induces changes in their transcriptional profile. Frontiers in Immunology. 14. 1192057–1192057.
2.
Møller, Lars, et al.. (2022). Omicron Outbreak at a Private Gathering in the Faroe Islands, Infecting 21 of 33 Triple-Vaccinated Healthcare Workers. Clinical Infectious Diseases. 75(5). 893–896. 28 indexed citations
3.
Møller, Lars, Peter Großmann, Katja Graf, et al.. (2022). Lactobacillus rhamnosus colonisation antagonizes Candida albicans by forcing metabolic adaptations that compromise pathogenicity. Nature Communications. 13(1). 3192–3192. 64 indexed citations
4.
Petersen, Maria Skaalum, Cecilie Bo Hansen, Marnar Fríðheim Kristiansen, et al.. (2021). SARS-CoV-2 Natural Antibody Response Persists for at Least 12 Months in a Nationwide Study From the Faroe Islands. Open Forum Infectious Diseases. 8(8). ofab378–ofab378. 15 indexed citations
5.
Petersen, Maria Skaalum, Marnar Fríðheim Kristiansen, Debes Hammershaimb Christiansen, et al.. (2021). Seroprevalence of SARS-CoV-2–Specific Antibodies among Quarantined Close Contacts of COVID-19 Patients, Faroe Islands, 2020. Emerging infectious diseases. 27(11). 2795–2801. 3 indexed citations
6.
Yu, Chao, Katharina Achazi, Lars Møller, et al.. (2014). Tick-Borne Encephalitis Virus Replication, Intracellular Trafficking, and Pathogenicity in Human Intestinal Caco-2 Cell Monolayers. PLoS ONE. 9(5). e96957–e96957. 19 indexed citations
7.
Hedrich, Dagmar, Paula Alves, Michael Farrell, et al.. (2011). The effectiveness of opioid maintenance treatment in prison settings: a systematic review. Addiction. 107(3). 501–517. 205 indexed citations
8.
Bergh, B.J. van den, Lars Møller, & Paul Hayton. (2010). Women’s health in prisons: It is time to correct gender insensitivity and social injustice. Public Health. 124(11). 632–634. 9 indexed citations
9.
Hayton, Paul, et al.. (2010). Health protection in prisons: the Madrid Recommendation. Public Health. 124(11). 635–636. 7 indexed citations
10.
Møller, Lars, A. Gatherer, & Masoud Dara. (2009). Barriers to implementation of effective tuberculosis control in prisons. Public Health. 123(6). 419–421. 11 indexed citations
11.
Møller, Lars, et al.. (2008). Drug use in prisons in Kyrgyzstan: a study about the effect of health promotion among prisoners. International Journal of Prisoner Health. 4(3). 124–133. 13 indexed citations
12.
Gatherer, A., Lars Møller, & Paul Hayton. (2005). The World Health Organization European Health in Prisons Project After 10 Years: Persistent Barriers and Achievements. American Journal of Public Health. 95(10). 1696–1700. 39 indexed citations
13.
Bladbjerg, Else‐Marie, Edith J. M. Feskens, Ronald P. Mensink, et al.. (2005). The plasminogen activator inhibitor-1 (PAI-1) promoter haplotype is related to PAI-1 plasma concentrations in lean individuals. Atherosclerosis. 181(2). 275–284. 16 indexed citations
14.
Hegaard, Hanne Kristine, Hanne Wacher Kjærgaard, Lars Møller, Henrik Wachmann, & Bent Ottesen. (2003). Multimodal intervention raises smoking cessation rate during pregnancy. Acta Obstetricia Et Gynecologica Scandinavica. 82(9). 813–819. 63 indexed citations
15.
Gram, Jørgen, Else‐Marie Bladbjerg, Lars Møller, Anette Sjøl, & Jørgen Jespersen. (2000). Tissue‐type plasminogen activator and C‐reactive protein in acute coronary heart disease. A nested case–control study. Journal of Internal Medicine. 247(2). 205–212. 52 indexed citations
16.
Bladbjerg, Else‐Marie, Lars Møller, & Jørgen Jespersen. (1998). Association of factor VII protein concentration with lifestyle factors. Scandinavian Journal of Clinical and Laboratory Investigation. 58(4). 323–330. 3 indexed citations
17.
Netterstrøm, Bo, Tage S. Kristensen, Lars Møller, Gorm Boje Jensen, & Peter Schnohr. (1998). Angina pectoris, job strain, and social status: A cross-sectional study of employed urban citizens. International Journal of Behavioral Medicine. 5(4). 312–322. 16 indexed citations
18.
Klausen, Ib Christian, Anette Sjøl, Peter S. Hansen, et al.. (1997). Apolipoprotein(a) isoforms and coronary heart disease in men. Atherosclerosis. 132(1). 77–84. 63 indexed citations
19.
20.
Møller, Lars & Thomas Kristensen. (1993). [Lead--a possible risk factor of increased blood pressure and cardiovascular disease].. PubMed. 155(40). 3203–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Phoebe Williams Breakdown of academic impact, for papers by Jenell S. Coleman Breakdown of academic impact, for papers by Manas K. Akmatov Breakdown of academic impact, for papers by Joann Schulte Breakdown of academic impact, for papers by Domenico Martinelli Breakdown of academic impact, for papers by Yasmin Khaliq Breakdown of academic impact, for papers by Massimo Pettoello‐Mantovani Breakdown of academic impact, for papers by Gayatri Jayaraman Breakdown of academic impact, for papers by Stan Houston Breakdown of academic impact, for papers by Jozefien Buyze
Rankless by CCL
2026